Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Betty Lamothe

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of the National Cancer Institute|June 26, 2008
Association between imatinib-resistant BCR-ABL mutation-negative leukemia and persistent activation of LYN kinaseJi Wu, Feng Meng, Ling-Yuan Kong, et al.
Science (New York, N.Y.)|August 29, 2009
The E3 ligase TRAF6 regulates Akt ubiquitination and activationWei-Lei Yang, Jing Wang, Chia-Hsin Chan, et al.
Nature Structural & Molecular Biology|May 26, 2009
E2 interaction and dimerization in the crystal structure of TRAF6Qian Yin, Su-Chang Lin, Betty Lamothe, et al.
The Journal of Biological Chemistry|June 22, 2011
Critical role of monoubiquitination of histone H2AX protein in histone H2AX phosphorylation and DNA damage responseChing-Yuan Wu, Hong-Yo Kang, Wei-Lei Yang, et al.
Nature|July 26, 2002
Distinct molecular mechanism for initiating TRAF6 signallingHong Ye, Joseph R Arron, Betty Lamothe, et al.
Acta Haematologica|August 3, 2018
A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid LeukemiaIman Abou Dalle, Jorge E Cortes, Pramod Pinnamaneni, et al.
Plos One|December 20, 2012
Deletion of TAK1 in the myeloid lineage results in the spontaneous development of myelomonocytic leukemia in miceBetty Lamothe, Yunju Lai, Lana Hur, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of the National Cancer Institute|June 26, 2008
Association between imatinib-resistant BCR-ABL mutation-negative leukemia and persistent activation of LYN kinaseJi Wu, Feng Meng, Ling-Yuan Kong, et al.
Science (New York, N.Y.)|August 29, 2009
The E3 ligase TRAF6 regulates Akt ubiquitination and activationWei-Lei Yang, Jing Wang, Chia-Hsin Chan, et al.
Nature Structural & Molecular Biology|May 26, 2009
E2 interaction and dimerization in the crystal structure of TRAF6Qian Yin, Su-Chang Lin, Betty Lamothe, et al.
The Journal of Biological Chemistry|June 22, 2011
Critical role of monoubiquitination of histone H2AX protein in histone H2AX phosphorylation and DNA damage responseChing-Yuan Wu, Hong-Yo Kang, Wei-Lei Yang, et al.
Nature|July 26, 2002
Distinct molecular mechanism for initiating TRAF6 signallingHong Ye, Joseph R Arron, Betty Lamothe, et al.
Acta Haematologica|August 3, 2018
A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid LeukemiaIman Abou Dalle, Jorge E Cortes, Pramod Pinnamaneni, et al.
Plos One|December 20, 2012
Deletion of TAK1 in the myeloid lineage results in the spontaneous development of myelomonocytic leukemia in miceBetty Lamothe, Yunju Lai, Lana Hur, et al.
Pageof 3